% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Faquih:270145,
author = {Faquih, Tariq O. and Landstra, Elvire N. and van Hylckama
Vlieg, Astrid and Aziz, N. Ahmad and Li-Gao, Ruifang and de
Mutsert, Renée and Rosendaal, Frits R. and Noordam, Raymond
and van Heemst, Diana and Mook-Kanamori, Dennis O. and van
Dijk, Ko Willems and Breteler, Monique M. B.},
title = {{P}er- and {P}olyfluoroalkyl {S}ubstances {C}oncentrations
are {A}ssociated with an {U}nfavorable {C}ardio-{M}etabolic
{R}isk {P}rofile: {F}indings from {T}wo {P}opulation-{B}ased
{C}ohort {S}tudies},
journal = {Exposure and health},
volume = {16},
issn = {2451-9766},
address = {[Dordrecht]},
publisher = {Springer Netherlands},
reportid = {DZNE-2024-00743},
pages = {1251 - 1262},
year = {2024},
abstract = {Per- and polyfluoroalkyl substances (PFAS) are widely used
and persistent chemicals, leading to ubiquitous exposure.
Although high PFAS levels have been associated with an
adverse cardiovascular risk profile, the distribution of
levels and relations with cardio-metabolic risk markers in
the general population have not been fully characterized. We
assessed the association between blood levels of
perfluorooctaneic acid (PFOA), perfluorooctane sulfonic acid
(PFOS), and perfluorohexanesulfonic acid (PFHxS) and a range
of lipoproteins and metabolites as well as clinical lipid
measurements. We used data from participants of the
Netherlands Epidemiology of Obesity study (NEO)
(n = 584) and the Rhineland Study (n = 1962),
jointly spanning an age range of 30 to 89 years. PFAS were
measured with the Metabolon HD4 platform, and lipoprotein
and metabolite profiles were measured using Nightingale’s
nuclear magnetic resonance-spectroscopy platform, and mainly
comprised lipoprotein markers. Using linear regression
analyses, we quantified age-, sex-, and education-adjusted
associations of PFOA, PFOS, and PFHxS with clinical lipid
measurements and 224 lipoproteins and metabolites. Higher
levels of PFAS, particularly PFOS and PFHxS, were associated
with higher concentrations of total lipid, cholesterol and
phospholipid content in most HDL, IDL, LDL, and VLDL
subclasses. The effect sizes were age-dependent for the
majority of the associations, with the deleterious effects
of PFAS being generally stronger in people below compared to
those above median age. Our observation that in the general
population even low PFAS concentrations are associated with
an unfavorable lipid profile, calls for further critical
regulation of PFAS substances.},
cin = {AG Breteler / AG Aziz},
ddc = {550},
cid = {I:(DE-2719)1012001 / I:(DE-2719)5000071},
pnm = {354 - Disease Prevention and Healthy Aging (POF4-354)},
pid = {G:(DE-HGF)POF4-354},
experiment = {EXP:(DE-2719)Rhineland Study-20190321},
typ = {PUB:(DE-HGF)16},
doi = {10.1007/s12403-023-00622-4},
url = {https://pub.dzne.de/record/270145},
}